Derman Antifungal Powder Tolnaftate Aerosol, Powder
NDC Package 81929-001-01

11-digit billing NDC: 81929000101

Package Information

Derman Antifungal Powder Tolnaftate (tolnaftate) aerosols is clean the affected area and dry thoroughlyshake can well before use: hold can about 6 inches from the area to be treatedapply a thin layer over the affected area twice daily (morning and night), or as directed by a doctorsupervise children in the use of this productuse daily for 4 weeks for athlete's foot and ringworm; use daily for 2 weeks for jock itchto prevent most athlete's foot apply once or twice daily (morning and/or night)if condition persists longer, consult a doctor this product is not effective on the scalp or nailsfor athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. This formulation utilizes a aerosol, powder delivery system. Marketed by Taisho Pharmaceutical California Inc., this product is identified by NDC 81929-001 and is authorized under FDA application M005.

Identification & Billing

NDC Package Code
81929-001-01
Package Description
1 CAN in 1 BOX / 130 g in 1 CAN
Product Code
11-Digit Billing Format
81929000101
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Derman Antifungal Powder Tolnaftate
Non-Proprietary Name
Tolnaftate
Substance Name
Tolnaftate
Dosage Form
Aerosol, Powder - A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Clean the affected area and dry thoroughlyshake can well before use: hold can about 6 inches from the area to be treatedapply a thin layer over the affected area twice daily (morning and night), or as directed by a doctorsupervise children in the use of this productuse daily for 4 weeks for athlete's foot and ringworm; use daily for 2 weeks for jock itchto prevent most athlete's foot apply once or twice daily (morning and/or night)if condition persists longer, consult a doctor this product is not effective on the scalp or nailsfor athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily

Regulatory & Marketing

Labeler Name
Taisho Pharmaceutical California Inc.
Product Type
Human Otc Drug
FDA Application #
M005
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-01-2022
End Marketing Date
11-30-2028
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81929-001-01 identifies a specific commercial package of 1 can in 1 box / 130 g in 1 can of Derman Antifungal Powder Tolnaftate, a human over the counter drug labeled by Taisho Pharmaceutical California Inc.. This aerosol, powder is formulated for topical use and contains tolnaftate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Taisho Pharmaceutical California Inc. on May 01, 2022.

How is this Taisho Pharmaceutical California Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81929000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81929-001-01
11-Digit CMS (5-4-2)
81929-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.